Teva Pharmaceuticals USA, Inc. has recalled 4,680 cartons of Amoxicillin and Clavulanate Potassium for Oral Suspension USP (200 mg/28.5 mg per 5mL) because the Clavulanate Potassium component was found to be subpotent. This medication is a prescription antibiotic used to treat various bacterial infections. The recall affects 100 mL bottles manufactured in Canada and distributed to Mississippi, Ohio, and California.
A subpotent drug may not provide the full intended dose of the antibiotic, which could lead to ineffective treatment of an infection and potentially contribute to antibiotic resistance. No injuries or illnesses have been reported to date.
You have 2 options:
Recall #: D-0151-2026; Manufactured by Teva Canada Limited for Teva Pharmaceuticals USA, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.